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Summary 
The screening of infectious agents (viruses, parasites or bacteria) in wildlife 
provides critical data regarding not only the presence of pathogens but also the diversity 
and the natural history of the target microbes. The emergence and re-emergence of 
diseases which originated from wildlife has emphasized the necessity for such pathogen 
assessment for the conservation of endangered animal populations, controlling the risk on 
the trade of wildlife or wildlife products, and preventing pathogen from spilling over into 
livestock or human population. In addition, the studies on infectious pathogens in the 
natural living great ape (gorillas, chimpanzees, etc.) populations has clarified the origins 
of some human viruses (HIV, HTLV, etc) as well as raising the concern about pathogen 
cross-species transmission between both hosts owing to the genetic relatedness between 
great apes and humans. 
I conducted the surveillance of adenovirus and bocaparvovirus infection in wild 
western lowland gorillas in Moukalaba-doudou National Park (Gabon) in order to 
investigate the presence, genetic diversity, and evolutionary history of these viruses, and 
to assess a possible zoonotic transmission for the case of adenoviruses. Although 
adenoviruses are widespread in humans and great apes, the data about the naturally 
occurring infections remain rare. On the other hand, the evolutionary study of 
adenoviruses infecting great apes has recently revealed that the Human mastadenovirus 
B (  originated from ancient gorillas and had experienced several cross-species 
(ape-ape and ape-human) transmission events. Bocaparvoviruses have been extensively 
studied because of their frequent association with respiratory illness and/or and 
gastroenteritis in humans. Although some bocaparvoviruses have been detected in non-
human primates (gorillas and chimpanzees), the presence, diversity, and evolution of 
these viruses are not fully understood. 
 On the other 
hand, HAdV-B was clustered with other gorilla adenoviruses together with human and 
chimpanzee strains, which support the hypothesis of being a zoonotic virus. The HAdV-
E was clustered with the chimpanzee strains. This result indicates the possibility of an 
ape-to-ape transmission of HAdV-E species because chimpanzees have been reported to 
be the most probable ancestor hosts of these viruses. 
Regarding the bocaparvorirus infection, I detected 
. The 
named Gorilla bocaparvovirus 2 (GBOV2) of this study is the first non-human primate 
bocaparovirus within that species. The molecular evolutionary analyses of primate 
bocaparvoviruses revealed the presence of inter and intra-species recombination events 
which might lead to the emergence of new bocaparvovirus variants in human as well as 
in non-human primate population.  
The description of several adenoviruses and the identification of novel 
bocaparvoviruses in wild western gorillas contribute to a better understanding of the 
genetic diversity of these viruses as well as clarifies their evolutionary processes. 
Although there is no evidence of gorilla-to-human interspecies transmission of the 
detected viruses in this study, I would advise the surveillance of these viruses in gorillas 
as well as in humans (tourists, guides, local peoples, etc.) which potentially contact with 
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Figure 1.1. Location features of the sampling area 
(A) Map of Gabon, showing MDNP. (B) The sampling area in the MDNP (blue line: 
rivers; black line: roads; red line: hunting area limitation; green line with black strips: 
national park limitation; dark green: primary forest; olive green: secondary forest; brown: 
savanna; spotted green: swamp; black circle: sampling points of G8 pointed by an arrow; 
gray circle pointed by an arrowhead: sampling points of GG; white circle: base camp; 
black rectangle with a black flag: village; white squares: habitations). 
Figure 1.2. Phylogenetic tree of adenovirus (AdV) DPOL 
The tree was constructed based on the alignment of AdV DPOL (539 bp) by using the 
neighbor-joining bootstrap-confirmed method in MEGA 5.05 software with 100 
replicates. The names of simian isolates include the serotype nomenclature and the animal 
species of isolation (Ch: chimpanzee, Go: gorilla, Bo: bonobo). Names of novel 
sequences obtained in this study are indicated with black dots. Bootstrap values less than 
90% are omitted. Scale bar, nucleotide substitutions per site.  
Figure 1.3. Phylogenetic tree of the adenovirus hexon gene loop 1 of HAdV-E 
The tree was constructed based on the alignment of a 792-bp sequence of the hexon gene 
by using the neighbor-joining bootstrap-confirmed method in MEGA 5.05 software with 
100 replicates. The names of simian isolates include the serotype nomenclature and the 
animal species of isolation (Ch: chimpanzee, Go: gorilla Bo: bonobo). Names of novel 
sequences obtained in this study are indicated with black dots. 
Figure 1.4. Phylogenetic tree of the partial sequence of DPOL 
The tree was constructed based on the alignment of AdV DPOL (539 bp) by using the 
neighbor-joining bootstrap-confirmed method in MEGA 5.05 software with 100 
replicates. The names of simian isolates include the serotype nomenclature and the animal 
species of isolation (Ch: chimpanzee, Go: gorilla, Bo: bonobo). Names of novel 
sequences obtained in this study are indicated with black dots. Bootstrap values less than 
90% are omitted. Scale bar, nucleotide substitutions per site.  
Figure 1.5. Phylogenetic tree of the partial sequence of the hexon gene 
The tree was constructed based on the alignment of a 792-bp sequence of the hexon gene 
by using the neighbor-joining bootstrap-confirmed method in MEGA 5.05 software with 
100 replicates. The names of simian isolates include the serotype nomenclature and the 
animal species of isolation (Ch: chimpanzee, Go: gorilla Bo: bonobo). Names of novel 
sequences obtained in this study are indicated with black dots. 
Figure 1.6. Phylogenetic tree of partial hexon of HAdV-D 
The tree was constructed based on the alignment of a 792-bp sequence of hexon gene by 
using the neighbor-joining bootstrap-confirmed method in MEGA 5.05 software with 100 
replicates. The names of simian isolates include the serotype nomenclature and the animal 
species of isolation (Ch: chimpanzee, Go: gorilla Bo: bonobo). Names of novel sequences 
obtained in this study are indicated with black dots. 
Figure 2.1. PCR strategy. (A) Schematic diagram of the PCR strategy. Scale, viral 
genome, and primers are shown. Gray arrows indicate primers used for detection and 
sequencing of bocaparvoviruses. The amplified regions are indicated by dashed gray 
lines. (B) Gel electrophoresis results showing the amplicon sizes of both positive samples. 
Figure 2.2. Genome organization of the gorilla bocaparvovirus 2. (A) The genome 
organization of GBOV2 is shown. The predicted ORFs are shown in boxes. The gray 
boxes are the regions shown in (B), (C), or (D). (B) A partial nucleotide alignment of the 
indicated viruses. The putative splice donor and acceptor are shown in boxes. (C) A 
partial alignment of deduced amino acid sequences of NS1 proteins. The conserved ATP-
binding Walker-Loop motif is indicated by the gray box. (D) An amino acid sequence 
alignment of partial VP1 proteins. The phospholipase A2 motif, which consists of the 
calcium binding region and catalytic residues, is indicated. 
Figure 2.3. Phylogenetic tree based on the complete coding sequences of primate 
bocaparvoviruses. The tree was reconstructed based on a nucleotide alignment of the 
complete coding sequence of the indicated viruses using the maximum likelihood method 
with 1000 bootstrap replicates. The GBOV2 sequences determined in this study are 
indicated with black dots. Bootstrap values of >70% are indicated at nodes. Scale bar, 
nucleotide substitutions per site. 
Figure 2.4. Phylogenetic tree based on the partial NS and VP2 genes of primate 
bocaparvoviruses. The tree was constructed based on the partial NS gene (486 b) (A) and 
VP gene (486 b) (B) using the maximum likelihood method with 1000 bootstrap 
replicates. The GBOV2 sequences obtained in this study are indicated with black dots. 
Bootstrap values of >70% are indicated at nodes. Scale bar, nucleotide substitutions per 
site. 
Figure 2.5. Recombination analysis. (A) Breakpoint detection using DualBrothers 
applied to the complete coding sequences of representative primate bocaparvoviruses. 
(B K) Phylogenetic trees were constructed based on partial alignments using the 
maximum likelihood method with 1000 bootstrap replicates. The nucleotide positions 
used for the phylogenetic inferences are indicated by blue letters. Bootstrap values of 
>70% are indicated at nodes 
Figure 2.6. A representation of individual gorillas constituting the target group based on 
body size and age categories. The red circles show the infected infants.
Figure 2.7. Phylogenetic tree based on the complete NS1 sequence. The tree was 
constructed based on the nucleotide sequences of complete NS1 using the maximum 
likelihood method with 1000 bootstrap replicates. The GBOV2 sequences obtained in this 
study are indicated with black dots. Bootstrap values of >70% are indicated at nodes. 
Scale bar, nucleotide substitutions per site.  
Figure 2.8. Phylogenetic tree based on the complete VP1 sequence. The tree was 
reconstructed based on the nucleotide sequences of complete NP1 using the maximum 
likelihood method with 1000 bootstrap replicates. The GBOV2 sequences determined in 
this study are indicated with black dots. Bootstrap values of >70% are indicated at nodes. 
Scale bar, nucleotide substitutions per site. 
Figure 2.9. Phylogenetic tree based on the complete NP1 sequence. The tree was 
constructed based on the nucleotide sequences of the complete NP1 gene using the 
maximum likelihood method with 1000 bootstrap replicates. The GBOV2 sequences 
obtained in this study are indicated with black dots. Bootstrap values of >70% are 
indicated at nodes. Scale bar, nucleotide substitutions per site.  
Table 1.1. Detection of adenovirus DPOL and hexon genes in samples from gorilla 
groups in MDNP 
Table 1.2. Adenovirus infection in humans 
Table 1.3. Primers and probe sequences for amplification of DPOL and hexon genes 
Table 1.4. Adenoviruses, accession number and hosts 
Table 2.1. Bocavirus infection prevalence in gorillas in MDNP 
Table 2.2. Primers used for sequencing the gorilla bocaparvovirus 2 
Table 2.3. Bocavirus sequences used for the phylogenetic inference 
Table 2.4. List of models used for the Maximum Likelihood test 
Table 2.5. Pairwise amino acid percentage identities of NS1 of GBOV2 and other primate 
bocaparvovirus reference strains.  
Table3.1. Diversity of viruses described in gorillas 
Epidemiological investigations of microorganisms (bacteria, parasites, viruses) 
infecting wild animals contribute to the understanding of the diversity and the 
evolutionary history of the target microbes.  For virus screening, two different approaches 
can be used: the antibody detection and  the virus or viral nucleic acid detection 
(Lehmkuhl and Hobbs, 2008; Luebcke et al., 2006; Mouinga-Ondémé et al., 2010; 
Oberste et al., 2013; Wevers et al., 2011). Sero-epidemiological surveys inform about 
which virus the animal has been exposed to (past or ongoing infections) (Makuwa et al., 
2006; Nidom et al., 2012; Rudicell et al., 2011; Starkman et al., 2003) and the virus 
isolation or viral nucleic acid detection  informs about the ongoing infections (Gál et al., 
2013; Wevers et al., 2010). The knowledge of the viral genetic sequence coupled with the 
phylogenetic characterization will contribute to the classification and the understanding 
of the diversity and the evolutionary history of the detected viruses.
Several molecular studies have revealed the close genetic relatedness between 
non-human primates and human viruses (Ahuka-Mundeke et al., 2010; Duncan et al., 
2013; Leendertz et al., 2011; Njouom et al., 2010; Scuda et al., 2011). For example, 
adenoviruses infecting human and apes cluster in the species Human adenvovirus B, C, 
E and F (Roy et al., 2009; Wevers et al., 2011). Similarly, primate bocaparvoviruses 
include human and non-human primate strains 
2010b; Sharp et al., 2010).
Additionally, approximately 75% of the diseases that have emerged or re-emerged 
over the past two decades have wildlife sources (Woolhouse et al., 2012) and great apes 
play a critical role regarding these zoonosis (Calvignac-Spencer et al., 2012).  Ape-to-
human zoonotic transmission is suggested for several viruses including the Human 
mastadenovirus-B (Hoppe et al., 2015), Ebolavirus (Leroy et al., 2011), the Human 
Immuno-Defiency virus (HIV)-I (Sharp and Hahn, 2010), the Human T-cell Leukemia 
virus (HTLV)-I (Junglen et al., 2010) or the spumavirus (Betsem et al., 2011).  
Despite the extensive research on the viruses infecting wild apes, their diversity 
and evolutionary history remain poorly understood. 
The object of this study is to investigate adenovirus and bocaparvovirus naturally 
occuring infections in wild gorillas using PCR in order to understand their diversity and 
evolution.  
In the first part of this thesis, I targeted the masdenoviruses infecting wild gorillas 
of Moukalaba-Doudou NationalPark and human (local people leaving nearby the park 
).  
Mastadenoviruses infect human and non-human primates (Duncan et al., 2013; 
Roy et al., 2009) and the human and non-human primate strains belong to the Human 
adenovirus species A to G (Pantó et al., 2015; Roy et al., 2009). Additionally, a recent 
report has documented about the Human mastadenovirus B originating from gorillas 
(Hoppe et al., 2015), and switched to human population and chimpanzees (Hoppe et al., 
2015) which highlights the ape-human and ape-ape cross-species transmission.  
 On the other 
hand, HAdV-B was clustered with other gorilla adenoviruses together with human and 
chimpanzee strains, which support the hypothesis of being a zoonotic virus. The HAdV-
E was clustered with the chimpanzee strains. This result indicates the possibility of an 
ape-ape transmission of HAdV-E species because chimpanzees have been reported to be 
the most probable ancestor hosts of these viruses. 
In the second part, I targeted bocaparvoviruses in wild gorillas. The viruses infecting 
human and non-human primates are grouped into 2 species named primate 
bocaparvoviruses. To date, 2 species of primate bocaparvoviruses have been described. 
Primate bocaparvovirus 1 and 2 (Allander et al., 2001; Arthur et al., 2009; Kapoor et al., 
2010b, 2009). A captive gorilla and a captive chimpanzee have been reported to be 
infected by the members of the species Primate bocaparvovirus 1 
Kapoor et al., 2010a); therefore the diversity of bocaparvoviruses infecting wild apes and 
their evolutionary history remain poorly understood.  
I detected 
. The named Gorilla bocaparvovirus 2 (GBOV2) of this 
study is the first non-human primate bocaparovirus within that species. The molecular 
evolutionary analyses of primate bocaparvoviruses revealed the presence of inter and 
intra-species recombination events which might lead to the emergence of new 
bocaparvovirus variants in human as well as in non-human primate population.  
The findings of this study contribute to a better understanding of the genetic diversity of 
mastadenoviruses and bocaparvoviruses infecting gorillas and provide insights to the 





Adenoviruses (AdVs) are non-enveloped icosahedral double-stranded DNA viruses. 
They belong to the family of Adenoviridae, which is divided into 5 genera: 
Mastadenovirus, Atadenovirus, Aviadenovirus, Siadenovirus, and Ichtadenovirus. 
Members of species belonging to genera Mastadenovirus and Atadenovirus are known to 
infect mammalian hosts (Lehmkuhl and Hobbs, 2008; Pantó et al., 2015). 
Mastadenoviruses infecting primates encompass 7 Human mastadenovirus species 
(HAdV-A to G), the accepted species Simian mastadenovirus A and candidate species 
SAdV-B to G (Chen et al., 2011), and further not yet classified mastadenoviruses (Chen 
et al., 2011; Gál et al., 2013; Pantó et al., 2015).  That classification into species or 
subgroups is based on hemagglutination features, DNA (Deoxyribonucleic acid 
homology, and genomic organization (Robinson et al., 2013).There are currently over 60 
HAdV types with HAdV-D containing the most members (Robinson et al., 2013). 
Adenoviruses were first isolated from humans and identified as the causative agent of 
epidemic febrile respiratory disease among military recruits in the 1950s (Hilleman and 
H., 1954; Rowe, et al., 1953). It is estimated that more than 90% of the human population 
is seropositive for one or more serotypes of adenoviruses 
Wadell et al., 1987). The molecular biology of human-derived adenoviruses has been 
characterized extensively for the species C group, for which HAdV 2 (HAdV-2) and 
HAdV-5 serve as prototypes (Fields, et al., 1996). Adenoviruses cause a variety of 
nonlethal infectious diseases in humans, and lethal disseminated adenovirus infection 
occurs in immunosuppressed patients (Fields, et al., 1996). 
The first description of a simian adenovirus in the literature was of a chimpanzee AdV 
(Rowe et al., 1956), today known as SAdV-21 within the species Human mastadenovirus 
B. Later, when investigating chimpanzees suffering from kuru, four novel apes AdVs 
were discovered (Rogers, et al., 1967). Ape AdVs have been detected or isolated from 
African apes including chimpanzees, bonobos and gorillas (Duncan et al., 2013; Hoppe 
et al., 2015; Roy et al., 2009; Seimon et al., 2015; Wevers et al., 2011, 2010). Gorilla 
adenoviruses have been proposed to be members of HAdV-B, C, E, and F (Duncan et al., 
2013; Hoppe et al., 2015; Roy et al., 2009; Seimon et al., 2015; Wevers et al., 2011, 2010). 
A recent report confirmed that the species HAdV-B which includes viruses from mixed 
host origin (Wevers et al., 2011), originated from gorillas and have switched to humans 
and to chimpanzees during 2 different host switch events (Hoppe et al., 2015). Serological 
surveys have found that anti-AdV antibodies were prevalent in 96% of mountain gorillas, 
suggesting that AdVs are circulating among these animals (Whittier, 2009). In addition, 
Hoppe et al. recently reported a high prevalence of AdV in wild apes including gorillas 
(45 to 100%) (Hoppe et al., 2015). Because AdVs are shed in the feces and saliva of 
infected animals (Roy et al., 2009), these viruses could possibly be transmitted among 
host animals via the fecal-oral route and inhalation of aerosols (Fong et al., 2010). 
Comprehensive studies are still needed to clarify the origin and the diversity of 
adenoviruses spread in human and non-human primate populations. Thus, to fill the gap, 
understanding the evolution pattern of AdVs spread in non-human primates and in people 
frequently coming in contact with these animals is critical. In this study, I investigated 
AdV infection in 2 habituated western lowland gorilla groups in MDNP. In addition, I 
assessed AdV infection in the local people living around the national park to evaluate 
potential zoonotic transmissions.  
II.2. Materials and Methods 
II.2.1. Sample collection and preparation 
The study site (MDNP) is located in the south-western part of Gabon (Fig. 1.2). 
MDNP has been reported to have a high gorilla density (more than 3 gorillas per square 
kilometer) (Ando et al., 2008), and the absence of hunting pressure from local villagers 
makes it a major habitat for western lowland gorillas in central Africa. From December 
2010 to November 2011, during tracking, we collected 112 fresh fecal samples from 2 
wild gorilla groups, which were named as Group Gentil (GG) and Group 8 (G8). GG and 
G8 had been habituated to human observers since 2003 (Ando et al., 2008) and 2011, 
respectively. During the study period, GG consisted of 20 21 individuals, including 1 
6 
years old) males, and 3 young females, and all members were individually identified. In 
contrast, G8 was estimated to consist of 8 12 individuals, including 1 adult male, 2 adult 
females, 5 8 young males and females. GG was mainly sampled near the village 
Doussala, in the ancient plantations, where the forest has been formerly used in various 
crop fields, while G8 was found far from the village in the primary forest (Fig. 1.2). In 
addition to the gorilla samples, 20 fecal samples were collected from villagers, including 
trackers working for the habituation of gorillas. Upon collection, each fecal specimen was 
immediately placed into a tube containing 2 ml of RNAlater (Ambion, Austin, TX, USA). 
The tubes were kept at room temperature for at most 20 days at the field camp until the 
samples were transported to the laboratory in Libreville, the capital city of Gabon. At the 
laboratory, the tubes were stored at 20°C until DNA extraction.
II.2.2. DNA extraction and PCR 
Total DNA was extracted from the sample by using the QIAamp DNA Stool Mini Kit 
ructions. I used the 
following primer sets for nested PCR: (1) 4431-s/4428-as and 4428-s/4429-as (Table 1.3), 
targeting the HAdV DPOL gene (Wevers et al., 2010) and (2) AdhexF1/AdhexR1 and 
AdhexF2/AdhexR2, targeting loop 1 encompassing the hypervariable region (HVR1
6) of the hexon gene of mastadenoviruses (Lu and Erdman, 2006). PCR for the DPOL 
gene was performed in a total volume of 20 µl containing 10 µl of 2×GoTaq Green Master 
Mix (Promega, Madison, WI, USA), 20 pmol of each primer, and 50 ng of DNA template. 
The following cycling conditions, slightly modified from Wevers et al. (Wevers et al., 
2010) were used: 95°C for 2 min; 35 cycles of 95°C for 30 s, 55°C for 1 min, and 72°C 
for 1 min; and a 7-min final extension step at 72°C. PCR amplification of the hexon gene 
(HVR1 6) was performed in a total volume of 50 µl containing 200 µM of each dNTP, 
20 pmol of each primer, 1.25 U of PrimeSTAR GXL polymerase (TaKaRa, Tokyo, 
Japan), and 50 ng of DNA template. The cycling conditions were as follows: 98°C for 3 
min; 35 cycles of 98°C for 10 s, 45°C for 1 min, and 72°C for 2 min; and a final extension 
of 72°C for 7 min. For the nested reaction, 2 µl of the first PCR was amplified as above. 
Amplified products were separated on 1.5% agarose gel and purified using the QIAquick 
were then directly sequenced with the primers for the second PCR.  
II.2.3. BLAST search 
BLAST searches were carried out in the NCBI database 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) using the determined nucleotide sequence as a 
query in the BLASTN program. The queries with at least 90% identity with the deposited 
adenovirus gene sequences were considered for AdV species identification. 
II.2.4. Sequencing and phylogenetic analysis 
Twenty-four of the 27 positive samples (DNA /µl), were subjected to 
direct sequencing of DPOL gene fragments. Six samples were selected randomly for 
cloning and sequencing of DPOL and hexon HVR1 6 gene fragments. The PCR products 
were cloned into plasmid vector pCR-Blunt II-TOPO using the Zero Blunt TOPO PCR 
Plasmid extraction was carried out using the Wizard Miniprep Kit (Promega), and the 
extracted plasmids were sequenced by Big Dye terminator cycle sequencing (Applied 
Biosystems, Foster City, CA, USA). 
The hexon HVR1 6 and DPOL gene sequences were edited and aligned using 
GENETYX software version 12.0 (Genetyx Co., Tokyo, Japan) and MEGA software 
version 5.05 (Tamura et al., 2011). The nucleotide sequences of DPOL (528-bp, 
corresponding to the position 29,200-29,727 in the reference simian adenovirus 21) and 
782-bp fragments of the hexon gene (corresponding to the position 18, 867-19,635 in the 
reference simian adenovirus 21) were aligned using MUSCLE, with the default 
parameters for gap opening and gap extension. These alignments were used for 
phylogenetic analyses. Phylogenetic trees were constructed using the maximum 
likelihood method in MEGA 5.05 (Tamura et al., 2011). A statistical test for the 
phylogeny was computed by means of bootstrapping. Percentages of 100 bootstrap 
replicates at the node were calculated to ensure the reliability of the trees. 
II.2.5. Nucleotide sequence accession numbers 
Preliminary names were given to candidate novel HAdVs following the method used 
by Wevers et al.(Wevers et al., 2010). The gorilla adenoviruses detected in this study were 
named as follows: Gorilla gorilla AdV B11-B23 (KM886307- KM886309, KM886311, 
KM886325- KM886328, KM886331- KM886335), Gorilla gorilla AdV C10-C18 
(KM886310, KM886320- KM886324, KM886329), and Gorilla gorilla AdV E1 
(KM886330). The sequences used as references for phylogenetic analysis are listed in 
Table 1.4. 
II.3 Results  
II.3.1. Detection of AdV genes in western lowland gorillas in MDNP 
To survey AdV infection in gorillas in MDNP, i collected fecal samples from 2 gorilla 
groups (GG: well-habituated group, G8: newly habituated group), and analyzed them by 
nested PCR targeting the DPOL and hexon genes.The DPOL and hexon genes were 
detected in both groups (Table 1.1). The overall prevalence of AdV in the gorilla 
population was 24.1% (27/112): of the 86 samples from GG, 21 were positive for both 
genes, 4 were positive only for the DPOL gene, and 1 sample was positive only for the 
hexon gene. In contrast, only 1 of the 26 samples was positive for both tested genes in G8 
(Table 1.1). These data suggest that AdVs are naturally circulating among gorillas in 
MDNP. To confirm the detected AdV species, I further determined the nucleotide 
sequences of the amplicons and determined the species of the detected AdVs by BLAST 
searches. Of the tested samples, 16 belonged to HAdV-B; 10 to HAdV-C; and 1 to HAdV-
E. 
II.3.2. Detection of AdV genes in local people living around the national park 
The prevalence of AdVs in well-habituated gorillas (30.2% in GG group) was higher 
than that of newly habituated ones (3.8% in G8 group), raising 2 possibilities either the 
AdVs in gorillas are derived from humans during the habituation process or AdVs are 
ubiquitous in the environment in and around areas of human habitation. Therefore, I 
screened the local people (village Doussala in Fig. 1.2) for AdV infection. The prevalence 
in the local people was 35.0 % (7/20): 2 samples were positive for both DPOL and hexon 
genes, and 5 were positive only for the hexon gene (Table 1.2). These results revealed 
that the local people including trackers were also infected with AdVs. 
 I sequenced the detected virus genes and identified the species of AdVs: 1 sample 
was infected with HAdV-C, and the others harbored HAdV-D. 
II.3. 3. Phylogenetic analysis 
HAdV-C genes were detected in both gorillas and humans in MDNP, suggesting 
zoonotic transmission of AdV between the human and gorilla populations. To investigate 
this possibility, as well as to gain insights into the genetic diversity of adenoviruses in 
MDNP, I performed phylogenetic analyses. 
In gorillas, in the tree based on the DPOL gene, the 14 AdV genes identified in this 
study were divided into 2 groups; they clustered with SAdV-28.2, SAdV-46, SAdV-47, 
and gorilla AdV strains 6589 and 6575, which are representative strains of HAdV-B in 
gorillas, and unidentified simian adenoviruses recently described (Hoppe et al., 2015) 
(Fig. 1.3 and 1.5). Nine AdV genes were clustered with simian AdV-45 and simian AdV-
43, which are representative strains of HAdV-C in gorilla and new unidentified simian 
adenoviruses (Hoppe et al., 2015) (Fig.1.3 and 1.5). In contrast, one AdV gene clustered 
with SAdV-26 and chimpanzee AdV strain Y25, which are chimpanzee-specific strains 
belonging to HAdV-E (Fig. 1.3 and 1.5). In the hexon gene-based trees, five HAdV-B 
(Figure 1.6.A), 1 HAdV-C (Figure 1.6.B), and 1 HAdV-E (Fig. 1.4) strains were 
identified among those isolated from gorillas. HADV-E is divided into 4 groups (Fig. 
1.4): 2 groups of human origin and 2 of simian origin. The HAdV-E detected in gorillas 
in this study belonged to the Human mastadenovirus E of simian origin (Fig. 1.4). 
In the case of humans, the tree based on the DPOL gene showed 1 AdV gene clustered 
with HAdV-1 (HAdV-C), which is genetically different from the strains detected in 
gorillas (Fig. 1.2 and 1.4.B), and 1 clustered with the human AdV type 53 and human 
AdV type 8, which belong to the HAdV-D (Fig. 1.3 and 1.7). The hexon gene-based tree 
showed that the detected viruses belonged to 4 different serotypes in HAdV-D group 
(Fig.1.7). The HAdV-D seems to be exclusively limited to the human population as 
reported earlier (Hoppe et al., 2015). 
II. 4. Discussion 
In this study, I detected several species of AdVs in western lowland gorillas in MDNP 
as well as in local people residing nearby. Interestingly, the positive rate in the well-
habituated group (30.2%) was higher than that of the newly habituated group (3.8%). In 
addition, members of HAdV-C were detected in both gorillas and humans. However, the 
phylogenetic analyses revealed that the AdVs detected from gorillas are genetically 
distinct from those from local people living around the national park. Therefore, gorilla 
viruses and human viruses may have been separately circulating in each population in this 
region, and transmission between human and animals does not seem to happen easily in 
both directions, although I cannot exclude the possibility that I just missed zoonotically 
transmitted AdVs in this study. The difference in the prevalence between groups GG and 
G8 may be attributed to the quality of samples, because samples from GG might have 
been fresher than the ones from G8; GG was sampled while following animals, but G8 
was sampled on trails, sometimes without observing the animals. In contrast, AdVs were 
reported to be transmitted between humans and non-human primates, indicating that 
AdVs have zoonotic potential (Hoppe et al., 2015; Wevers et al., 2011) despite the belief 
that AdVs have co-evolved with their hosts and are usually not transmitted to other 
species.  
populations as well as in other great apes (Hoppe et al., 2015; Seimon et al., 2015; Wevers 
et al., 2011). In this study, the overall prevalence of AdV infection in gorillas was 24.1%, 
which is lower than the previously reported figure of 44.9% in free-ranging gorillas in 
Congo Republic (Seimon et al., 2015) or of 48 % in free-ranging gorillas in Loango 
National Park (Gabon) (Hoppe et al., 2015). These differences might be due to the quality 
of the samples and/or sensitivity of the PCR. In addition, the PCR systems used in this 
study targeted the conserved DPOL gene of mastadenovirus or the hypervariable region 
of the hexon gene, but in some samples, only 1 of the 2 genes was amplified. This shows 
that my PCR system might not be able to amplify all AdV genes or that the samples could 
have been partially degraded, or simply natural differences (Hoppe et al., 2015). 
Alternatively, AdV prevalence in the gorillas included in this study was low. Further 
systematic studies are needed to assess these possibilities. 
I detected members of 3 species: HAdV-B, HAdV-C, and HAdV-E in western 
lowland gorillas in MDNP; these AdV species have been reported earlier (Duncan et al., 
2013; Hoppe et al., 2015; Seimon et al., 2015; Wevers et al., 2011) in western lowland 
gorillas as well as in other gorilla sub-species in sub-Saharan Africa. The gorilla 
adenoviruses of this study mainly belong to the HAdV-B (59%). This confirms the gorilla 
as the major host of HAdV-B in sub-Saharan Africa. Based the hexon tree ( Fig.1.6 A), 
the new virus named Gorilla gorilla adenovirus B19, together with the human 
mastadenovirus B isolates 6560 and 6674 constitute  a single clade probably originating 
from gorillas. The pattern observed within the species Human mastadenovirus C (Fig. 1.6 
B) is compatible with the host-pathogen divergence as previously reported (Hoppe et al., 
2015; Roy et al., 2009; Wevers et al., 2011). All the lineages in HAdV-C are host specific 
(Hoppe et al., 2015). The only member of HAdV-E detected in this study clusters with 
chimpanzee strains (Fig. 1.4). This finding supports previous report describing the non-
human primate AdVs members of the HAdV-E to originate from chimpanzees (Hoppe et 
al., 2015). I can suspect the Gorilla gorilla adenovirus E1 of this study to be the result of 
chimpanzee-to-gorilla transmission, as chimpanzees and gorillas are living sympatrically 
in MDNP. Broader screening would clarify the evolution of viruses belonging to HAdV- 
E. 
On the other hand, the adenovirus-like genes detected in the human population around 
MDNP are mainly members of the HAdV- D (85.71%) which confirms that the species 
HAdV-D originated in humans (Hoppe et al., 2015) and so far has been exclusively 
human specific. Therefore, 4 different serotypes were detected in this study; highlighting 
the diversity of adenoviruses circulating in the target human population. Further 
systematic studies should clarify the the circulation of AdVs in human population. 
Taken together, my results show that AdVs are naturally present among gorillas and 
humans in MDNP in Gabon. Although there is no evidence of zoonotic transmission of 
AdVs in this region, my data shows de feasibility of monitoring viral agents in wild 
habituated gorillas (Gilardi et al., 2015) and in local people living nearby for the safe 
management of wild gorilla populations and human health, as well as for understanding 
the evolution of virus. Since the zoonotic transmission of adenovirus already occurred 
during hominin evolution, assessing the zoonotic transmission of that virus in the context 
of habituation sites such as MDNP is recommended. 




No. of tested 
samples 
No. of positive 
samples in PCR (%)
Species 
No. of samples 
B C               E 
GG 86 26 (30.2%) 16 9               1 
G8 26 1 (3.8%) 0            1 0 
Total 112 27 (24.1%) 16 10               1 
Table 1.2. Adenovirus infection in humans 































Table 1.4.: Adenoviruses, accession number and hosts




HAdV-B of this study 
Gor. gorilla adenovirus B11 Ggor AdV 
B11 
KM886307 Gorilla + 
Gor. gorilla adenovirus B12 Ggor AdV 
B12 
KM886308 Gorilla +  
Gor. gorilla adenovirus B13 Ggor AdV 
B13 
KM886309 Gorilla +  
Gor. gorilla adenovirus B14 Ggor AdV 
B14 
KM886311 Gorilla + 
Gor. gorilla adenovirus B15 Ggor AdV 
B15 
KM886314 Gorilla + 
Gor. gorilla adenovirus B16 Ggor AdV 
B16 
KM886315 Gorilla +  
Gor. gorilla adenovirus B17 Ggor AdV 
B17 
KM886317 Gorilla +  
Gor. gorilla adenovirus B18 Ggor AdV 
B18 
KM886319 Gorilla + 
Gor. gorilla adenovirus B19 Ggor AdV 
B19 
KM886325 Gorilla + 
Gor. gorilla adenovirus B20 Ggor AdV 
B20 
KM886326 Gorilla +  
Gor. gorilla adenovirus B21 Ggor AdV 
B21 
KM886327 Gorilla +  
Gor. gorilla adenovirus B22 Ggor AdV 
B22 
KM886328 Gorilla + 
HAdV-C of this study 
Gor. gorilla adenovirus C10 Ggor AdV 
C10 
KM886310 Gorilla +  
Gor. gorilla adenovirus C11 Ggor AdV 
C11 
KM886312 Gorilla +  
Gor. gorilla adenovirus C12 Ggor AdV 
C12 
KM886313 Gorilla + 
Gor. gorilla adenovirus C13 Ggor AdV 
C13 
KM886320 Gorilla + 
Gor. gorilla adenovirus C14 Ggor AdV 
C14 
KM886321 Gorilla +  
Gor. gorilla adenovirus C15 Ggor AdV 
C15 
KM886322 Gorilla +  
Gor. gorilla adenovirus C16 Ggor AdV 
C16 
KM886323 Gorilla + 
Gor. gorilla adenovirus C17 Ggor AdV 
C17 
KM886324 Gorilla + 
Gor. gorilla adenovirus C18 Ggor AdV 
C18 
KM886329 Gorilla +  
HAdV E of this study 
Gor. gorilla adenovirus E1 Ggor AdV E1 KM886330 gorilla + 
Reference sequences used for phylogeny 
Gorilla gorilla adenovirus 1 Ggor AdV1 Wevers et 
al.,2011 
Gorilla +  




Gorilla +  
6575 Gor. gor. adenovirus  








Human adenovirus type 31 HAdV-A-31 AM749299 
Human adenovirus type 1 HAdV-C AF534906 
Human adenovirus D-8 HAdV D-8 AB448767 
Human adenovirus D-53 HAdV D-53 FJ169625 
Human_adenovirus_D_strain_human/CA  HQ007053 
Human_adenovirus_D_isolate_hu4555_UG_  KF976533 
Human_adenovirus_26_:_BP-2_ AB330107 
Human_adenovirus_62 JN162671 
Human_adenovirus_69  JN226748 
Human_adenovirus_29  JN226754 
Human_adenovirus_D KF976527 
Human_adenovirus_54 AC000006 
Human_adenovirus_9  NC010956 
Human_adenovirus_10  NC012959 
Human_adenovirus_15 AJ854486 
Human_adenovirus_13 AB330091 
Human_adenovirus_17  AB562586 
Human_adenovirus_19_  JN226747 
Human_adenovirus_20_ HQ910407 
Human_adenovirus_22_ JQ326209 
Human_adenovirus_22_  JN226749 
Human_adenovirus_23_  FJ619037 
Human_adenovirus_24_ KF279629 
Human_adenovirus_25_ JN226751 
Human_adenovirus_27_  JN226752 
Human_adenovirus_28_  JN226753 
Human_adenovirus_30_ FJ824826 
Human_adenovirus_32_ JN226755 
Human_adenovirus_33_  JN226756 
Human_adenovirus_36_  JN226758 
Human_adenovirus_37_ GQ384080 
Human_adenovirus_38_ AB448778 
Human_adenovirus_39_  JN226759 




Human adenovirus type 4c HAdV-4 AY594253 
Human adenovirus type 4d HAdV-4 AY594254 
Human adenovirus type 4e HAdV-4 AY599835 
Human adenovirus -E HAdV-E X74508 
Human adenovirus-E HAdV-E AY487947 
Human adenovirus-E HAdV-E EF371058 
Human adenovirus type 4f HAdV-4 AY599837 
Human adenovirus type 4g HAdV-4 KF006344 
Human adenovirus F-40 HAdV F-40 NC_001454 
Human adenovirus F-41 HAdV-41 DQ 315364 
Human adenovirus G- 52 HAdV G-52 DQ 923122 
Simian adenovirus 1 SAdV-1 AY771780 OWMb
Simian adenovirus 3 SAdV-3 AY598782.1 OWMb
Simian adenovirus 28.2 SAdV -28.2 FJ025915 Gorilla  + 
Simian adenovirus 46 SAdV-46 FJ025930 Gorilla + 
Simian adenovirus 45 SAdV-45 FJ025901 Gorilla + 
Simian adenovirus 48 SAdV-48 HQ241818.1 OWMb  + 
Simian adenovirus 24 SAdV-24 AY530878.1 Chimpanzee  + 
Simian adenovirus 37.2 SAdV-37.2 FJ025919 Bonobo + 
Simian adenovirus 38 SAdV-38 FJ025922 Chimpanzee + 
Simian adenovirus 30 SAdV-30 FJ025920 Chimpanzee  + 
Bovine adenovirus B BAdV-B-3 AC000002 
Unidentified simian adenovirus strain u5753 LN829111 Chimpanzee + 
Unidentified simian adenovirus strain u7312 LN829046 Gorilla + 
Unidentified simian adenovirus strain u7304  LN829045 Gorilla  + 
Unidentified simian adenovirus strain u7289  LN829041 Gorilla  + 
Unidentified simian adenovirus strain u7283 LN829040 Gorilla + 
Unidentified simian adenovirus strain u7280 LN829039 Gorilla + 
Unidentified simian adenovirus strain u7264  LN829038 Gorilla  + 
Unidentified simian adenovirus strain u7261  LN829037 Gorilla  + 
Unidentified simian adenovirus strain u6208 LN829036 Chimpanzee + 
Unidentified simian adenovirus strain u7259 LN829034 Bonobo + 
Unidentified simian adenovirus strain u7258  LN829033 Bonobo  + 
Unidentified simian adenovirus strain u7257  LN829032 Bonobo  + 
Unidentified simian adenovirus strain u7256 LN829031 Bonobo + 
Unidentified simian adenovirus strain u7255 LN829030 Bonobo + 
Unidentified simian adenovirus strain u7254  LN829029 Bonobo  + 
Unidentified simian adenovirus strain u7253  LN829028 Bonobo  + 
Unidentified simian adenovirus strain u7252 LN829027 Bonobo + 
Unidentified simian adenovirus strain u7251 LN829026 Bonobo + 
Unidentified simian adenovirus strain u7250  LN829025 Bonobo  + 
Unidentified simian adenovirus strain u7248  LN829024 Bonobo  + 
Unidentified simian adenovirus strain u7246 LN829023 Bonobo + 
Unidentified simian adenovirus strain u7244 LN829022 Bonobo + 
Unidentified simian adenovirus strain u7243  LN829021 Bonobo  + 
Unidentified simian adenovirus strain u7242  LN829020 Bonobo  + 
Unidentified simian adenovirus strain u7241 LN829019 Bonobo + 
Unidentified simian adenovirus strain u7239 LN829018 Bonobo + 
Unidentified simian adenovirus strain u7237  LN829017 Bonobo  + 
Unidentified simian adenovirus strain u7236  LN829016 Bonobo  + 
Unidentified simian adenovirus strain u7231 LN829015 Bonobo + 
Unidentified simian adenovirus strain u7230 LN829014 Bonobo + 
Unidentified simian adenovirus strain u7229  LN829013 Bonobo  + 
Unidentified simian adenovirus strain u7228  LN829012 Bonobo  + 
Unidentified simian adenovirus strain u7227 LN829011 Bonobo + 
Unidentified simian adenovirus strain u7226 LN829010 Bonobo + 
Unidentified simian adenovirus strain u7225  LN829009 Bonobo  + 
Unidentified simian adenovirus strain u7224  LN829008 Bonobo  + 
Unidentified simian adenovirus strain u7315 LN829004 Gorilla + 
Unidentified simian adenovirus strain u7287 LN828995 Gorilla + 
Unidentified simian adenovirus strain u7273  LN828990 Gorilla  + 
Unidentified simian adenovirus strain u7268  LN828988 Gorilla  + 
Unidentified simian adenovirus strain u7265 LN828987 Gorilla + 
Unidentified simian adenovirus strain u6776 LN828984 Gorilla + 
Unidentified simian adenovirus strain u6588  LN828983 Gorilla  + 
Unidentified simian adenovirus strain u6575  LN828982 Gorilla  + 
Unidentified simian adenovirus strain u6565 LN828981 Gorilla + 
Unidentified simian adenovirus strain u6560 LN828980 Gorilla + 
Unidentified simian adenovirus strain u3135  LN828979 Chimpanzee  + 
Unidentified simian adenovirus strain u6211  LN828978 Chimpanzee  + 
Unidentified simian adenovirus strain u5052 LN829047 Gorilla + 
Unidentified simian adenovirus strain u7297 LN829044 Gorilla + 
Unidentified simian adenovirus strain u7296  LN829043 Gorilla  + 
Unidentified simian adenovirus strain u7294  LN829042 Gorilla  + 
Unidentified simian adenovirus strain u6480 LN829007 Gorilla + 
Unidentified simian adenovirus strain u5855 LN829006 Gorilla + 
Unidentified simian adenovirus strain u7317  LN829005 Gorilla  + 
Unidentified simian adenovirus strain u7314  LN829003 Gorilla  + 
Unidentified simian adenovirus strain u7311 LN829001 Gorilla + 
Unidentified simian adenovirus strain u7306 LN829000 Gorilla + 
Unidentified simian adenovirus strain u7302  LN828999 Gorilla  + 
Unidentified simian adenovirus strain u7295  LN828997 Gorilla  + 
Unidentified simian adenovirus strain u7293 LN828996 Gorilla + 
Unidentified simian adenovirus strain u7278 LN828994 Gorilla + 
Unidentified simian adenovirus strain u7276  LN828993 Gorilla  + 
Unidentified simian adenovirus strain u7275  LN828992 Gorilla  + 
Unidentified simian adenovirus strain u7274 LN828991 Gorilla + 
Unidentified simian adenovirus strain u7270 LN828989 Gorilla + 
Unidentified simian adenovirus strain u7262  LN828986 Gorilla  + 
Unidentified simian adenovirus strain u7260  LN828985 Gorilla  + 
Unidentified simian adenovirus strain u7310 LN828977 Gorilla + 
aCaptive: zoo animals         bOWM: Old world monkey    c: strain RI-67, d: vaccine strain, e: strain NHRC 42606, f: strain NHRC 3, 
g: strain GZ01 
Fig.1.1. Location features of the sampling area 
Fig.1.2. Phylogenetic tree of adenovirus (AdV) DPOL 






Human adenovirus E isolate NHRC90339_EF371058
Bovine adenovirus 3_AF030154
Human adenovirus E_AY487947
Human adenovirus type 4 vaccine strain_AY594254
Human adenovirus type 4 strain RI-67_AY594253
100
Human adenovirus type 4 strain GZ01_KF006344
Human adenovirus type 4 strain NHRC3_AY599837
Human adenovirus type 4 strain NHRC42606_AY599835
Gorilla gorilla adenovirus E1_KM886330
Simian adenovirus 39_FJ025924.Ch
Simian adenovirus 30_FJ025920.Ch
Chimpanzee adenovirus Y25_JN254802 
Pan troglodites schweinfurthii adenovirus 13_JN163983





Simian adenovirus 28 2 FJ025915.Go
Gorilla gorilla adenovirus B20 KM886326
Gorilla gorilla adenovirus B22 KM886328
Simian adenovirus 47 FJ025929.Go
Gorilla gorilla adenovirus B17 KM886317
Gorilla gorilla adenovirus B13 KM886309
Gorilla gorilla adenovirus B12 KM886308
Gorilla gorilla adenovirus B18 KM886319
Gorilla gorilla adenovirus B11 KM886307
Gorilla gorilla adenovirus B16 KM886315
Simian adenovirus 27 1 FJ025909.Ch
Simian adenovirus -46 FJ025930.Go
Simian adenovirus 27.1 KM886316
Simian adenovirus 27.1 KM886318
Gorilla gorilla adenovirus B14 KM886311
Simian adenovirus 29 FJ025916.Ch
Gorilla gorilla adenovirus B15 KM886314
Simian adenovirus 28 1 FJ025914.Ch
Simian adenovirus 27 2 FJ025928.Go
Simian adenovirus 32 FJ025911.Ch
Simian adenovirus 41 1 FJ025913.Go
Simian adenovirus 41 2 FJ025927.Go
Human adenovirus type 3 strain NHRC 1276 AY599836
Human adenovirus 7 KP670861
Human adenovirus 21 KJ364592
Human adenovirus type 50 AY737798
Human adenovirus type 16 AY601636
Gorilla gorilla adenovirus B19 KM886325
Gorilla gorilla adenovirus B21 KM886327
Human mastadenvoris B isolate 6588 KM659150.Go   
Human mastadenvoris B isolate 6575 KM659142.Go
Human adenovirus 55 KC857701
Human adenovirus 14 JN032132
Human adenovirus type 34 AY737797
Human adenovirus type 35 AC 000019
Human adenovirus type 11 strain Slobitski AF532578
Human adenovirus type 4 vaccine strain AY594254
Human adenovirus type 4 strain RI-67 AY594253
Human adenovirus E AY487947
Human adenovirus E isolate NHRC90339 EF371058
Human adenovirus E X74508
Human adenovirus type 4 strain NHRC 42606 AY599835
Human adenovirus 4 strain GZ01 KF006344
Human adenovirus type 4 strain NHRC 3 AY599837
Pan troglodites adenovirus1
Gorilla gorilla adenovirus E1 KM886330
Simian adenovirus 26 FJ025923.Ch
Chimpanzee adenovirus Y25 JN254802
Simian adenovirus 39 FJ025924.Ch
Simian adenovirus 38 FJ025922.Ch
Simian adenovirus 25.2 FJ025918.Ch
Simian adenovirus 25 2 FJ025918.Ch
Simian adenovirus 24 strain ATCC VR-593 AY530878.Ch
Simian adenovirus 36 FJ025917.Ch
Simian adenovirus 23 strain ATCC VR-592 AY530877.Ch
Simian adenovirus 37.1 FJ025921.Ch
Simian adenovirus 30 FJ025920.Ch
Simian adenovirus 37.2 FJ025919.Bo
Human adenovirus type 26 EF153474
Human adenovirus 33 JN226758
Human adenovirus 39 JN226760
Human adenovirus 45 JN226764
Human adenovirus 43 JN226762
Human adenovirus 69 JN226748
Human adenovirus 47 JN226757
Human MK17_KU523571
Human adenovirus 44 JN226763
Human adenovirus 56 LC066535
HAdV D strain human/DEU/IAI-1/2005/53 FJ169625
Human adenovirus 8 strain: Trim variant AB746853
Human adenovirus type 48 EF153473
Human adenovirus 58 HQ883276
Human adenovirus 15 AB562586
Human adenovirus 29 JN226754
Simian adenovirus -48 isolate AJ75 HQ241818.Cy
Simian adenovirus 3 strain ATCC VR-1449 AY598782.Rh
Human adenovirus 6 FJ349096
Human adenovirus 2 AC 000007
Human adenovirus 5 AC 000008
Human adenovirus type 1 AC 000017
Human adenovirus type 1 (HAdV- C) AF534906
Human MK1_KU523570
Gorilla gorilla adenovirus C14 KM886321
Gorilla gorilla adenovirus C16 KM886323
Gorilla gorilla adenovirus C17 KM886324
Gorilla gorilla adenovirus 1
Gorilla gorilla adenovirus C15 KM886322
Gorilla gorilla adenovirus C10 KM886310
Gorilla gorilla adenovirus C12 KM886313
Gorilla gorilla adenovirus C17 KM886329
Gorilla gorilla adenovirus C11 KM886312
Simian adenovirus 43 FJ025900.Go
Gorilla gorilla adenovirus C13 KM886320
Simian adenovirus -45 FJ025901.Go
Human adenovirus 18 GU191019
Human adenovirus type 31 AM749299
Human adenovirus 12 X73487
Pan troglodites adenovirus 5
Human adenovirus -40 NC 001454
Simian adenovirus -7 DQ792570.Rh ATCC
Human adenovirus -52 isolate T03-2244 DQ923122






































Figure 1.4. Phylogenetic tree of the partial sequence of DPOL
Fig. 1.5. Phylogenetic tree of the partial sequence of the hexon gene 









 Human mastadenovirus B isolate 6560 KM659138



















Human adenovirus 22 FJ619037
Human adenovirus 53 KF268197
Human adenovirus 49 DQ393829
Human adenovirus 27 JN226753
Human adenovirus 28 FJ824826
Human MK11_KU523574
Human adenovirus 44 JN226763
Human adenovirus 48 EF153473
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Human adenovirus 19 JQ326209
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Human adenovirus 51 JN226765
Human adenovirus 8 AB500121
Human adenovirus 24 JN226751
Human adenovirus 36 GQ384080
Human adenovirus 38 JN226759
Human adenovirus 33 JN226758
Human adenovirus 58 HQ883276
Human MK17_KU523576
Human adenovirus 39 JN226760
Human adenovirus 43 JN226762
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Human adenovirus 37 AB448778
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Human adenovirus 10 AB330091
Human adenovirus 17 HQ910407
Human adenovirus 20 JN226749
Human adenovirus 42 JN226761
Human adenovirus 9 AJ854486
Human adenovirus 32 JN226756
Human adenovirus 54 NC012959
Human adenovirus 23 KF279629
Human adenovirus 56 LC066535
Human MK8_KU523573
Human adenovirus 69 JN226748
Human adenovirus 29 JN226754
















 Bocaparvoviruses have been studied extensively owing to their ability to cause 
respiratory illness or gastroenteritis in humans. Some bocaparvoviruses have been 
detected in non-human primates (gorillas and chimpanzees), but the diversity and 
evolution of these viruses are not fully understood. In this study, 
 wild western lowland gorillas in MDNP in Gabon to investigate the 
presence of bocaparvoviruses. Using a combination of pan-bocaparvovirus PCR 
. To my knowledge, this is the 




Bocaparvoviruses belong to the genus Bocaparvovirus of the sub-family 
Parvovirinae and the family Parvoviridae. Currently, 12 species have been reported in 
the genus: Carnivore bocaparvovirus 1 3, Pinniped bocaparvovirus 1 and 2, Primate 
bocaparvovirus 1 and 2, and Ungulate bocaparvovirus 1 5 (Cotmore et al., 2014; ICTV, 
2016). Further viruses, genetically related, recently described have not been classified yet 
(Guo et al., 2016; Lanave et al., 2015; Lau et al., 2017; Yang et al., 2016). Members of 
Primate bocaparvovirus 1 and 2 are known to infect human and non-human primate hosts 
2010b, 2009; Sharp et al., 2010). The first primate bocaparvovirus was detected in 
humans in 2005 from pooled nasopharyngeal aspirate specimens by large-scale molecular 
virus screening (Allander et al., 2005). Since then, many molecular epidemiological 
studies have suggested that human bocaviruses (HBOV) are associated with respiratory 
or gastrointestinal illnesses (Ahn et al., 2014; Arthur et al., 2009; Jin et al., 2011; Lu et 
al., 2015; Medici et al., 2012; Nunes et al., 2014; Phan et al., 2012). Additionally, some 
bocaparvoviruses have been detected from non-human primates, such as gorillas (Kapoor 
et al., 2010a, Sharp et al., 2010) and chimpanzees  Sharp et al., 
2010). Currently, Primate bocaparvovirus 1 can be classified into four genotypes, 
including human and non-human primate bocaparoviruses: HBOV1, HBOV3, gorilla 
bocavirus 1 (GBOV1), and primate bocaparvovirus 1 isolate CPZh2 (Allander et al., 
l., 2010a, 
2010b).  Primate bocaparvovirus 2 includes only two genotypes: HBOV2 and HBOV4 
(Cotmore et al., 2014; Kapoor et al., 2009, 2010b; Khamrin et al., 2013). 
Bocaparvoviruses are small non-enveloped viruses with a linear single-stranded 
DNA genome of approximately 4.9 5.5 kb. The viral genome contains three major open 
reading frames (ORFs); the left ORF encodes a non-structural protein (NS1) involved in 
replication (Allander et al., 2005), the right ORF encodes the viral capsid proteins (VP1 
and VP2), and the middle ORF is a unique feature of bocaparvoviruses in the family 
Parvoviridae and encodes the highly phosphorylated non-structural protein NP1. 
Although primate bocaparvoviruses have been detected in diseased and healthy gorillas 
and chimpanzees , the clinical significance or 
symptoms in apes is unknown thus far. Additionnally, bocaparvovirus-like genes have 
been found in healthy free-ranging  gorillas (prevalence: 36%) and chimpanzees 
(prevalence: 73%) (Sharp et al., 2010); However, the diversity and evolution of 
bocaparvoviruses infecting wild apes remain poorly understood.  
In this study, I have investigated the bocaparvovirus infection in wild western 
lowland gorillas (Gorilla gorilla gorilla) in MDNP, Gabon. I have detected a novel 
bocaparovovirus genotype and characterized the nearly complete genome of two novel 
gorilla bocaparvoviruses that form a single cluster within the species Primate 
bocaparvovirus 2.  
III.2. Material and methods 
III.2.1. Sample collection and DNA extraction 
Between November and December 2014, 107 fresh fecal samples were collected 
from wild western lowland gorillas subjected to habituation in MDNP, Gabon (Ando et 
al., 2008). During the sample collection period, the target gorilla group included one adult 
male or silverback (estimated age, >13 years old), four adult females (estimated age, >10 
years old), two sub-adults (estimated age, >6 years old), eight juveniles (estimated age, 
4 6 years old), and three infants (estimated age, <3 years old) (Table 2.1). 
Opportunistically, other individual wild gorillas sharing the same home range with the 
target group were sampled. Gorillas were followed daily as part of the habituation process 
and fecal samples were collected on trails when following the animals. To detect 
bocaparvoviruses, few grams of the feces were taken using a sterile plastic stick and 
preserved in 5 ml of RNAlater (Ambion, Austin, TX, USA). In addition, for individual 
dual g the 
surface of each feces, which contains gorilla-derived tissues, were scratched using a 
cotton swab. The swabs were preserved in 1 ml of lysis buffer (0.5% SDS, 100 mM 
EDTA, 100 mM Tris-HCl, and 10 mM NaCl) until DNA extraction. The following 
information: date, time, GPS coordinates, and fecal diameter were recorded upon 
collection. To prevent cross contamination, fecal collection were performed using 
disposable plastic sticks and protective gloves were used once. DNA was extracted from 
both samples using the QIAamp DNA Stool Mini Kit (QIAGEN, Hilden, Germany), 
following t
III.2.2. Individual genetic identification  
To identify gorilla individuals, multiplex PCR was performed using QIAGEN 
Multiplex PCR Kits (QIAGEN), as described by (Inoue et al., 2013), with host DNA 
extracted from the swab samples of feces from gorillas. One primer set was used for six 
autosomal microsatellite loci (D7s817, D1s550, vWF, D1s2130, D7s794, and D6s1056 
(Inoue et al., 2013). Genotype data for target individuals were already available and 
genetic variation at these six loci was sufficient to identify individuals (Inoue et al., 
unpublished results). After PCR to amplify these microsatellite loci, genotypes were 
determined using Peak Scanner V1.0 (Applied Biosystems, Foster City, CA, USA).  
III.2.3. PCR detection of bocaparvovirus  
 The samples were tested for the presence of bocaparvovirus DNA by hemi-nested 
-
PanBov- -GTACAGTCRTAYTCRTTRAARCACCA-
and PanBov- -GCAYCARGAYTGGGTIGANCCWGC- -R1 for the 
second round of PCR, according to Kapoor et al., 2010a. The first-round PCR was 
 of Phusion High-fidelity DPOL 
(Thermo-
HF 
nd PCR product as the template. The PCR 
strategy and the expected size of bands are shown in Fig. 2.1A-B. The amplicons were 
directly purified using the Innuprep PCR pure kit (Analytik Jena, Jena, Germany) or gel 
extracted using the NucleoSpin ® gel and PCR clean-up kit (Macherey Nagel, Düren, 
Germany) according to t
III.2.4. Sequencing of the gorilla bocaparvoviruses 
To determine the nearly complete genome sequence of the detected 
bocaparvoviruses, additional primers were designed (Table 2.2) and PCR and sequencing 
were performed using a primer walking approach (by direct-sequencing). Each PCR 
fragment was read at least twice with both forward and reverse primers. GENETYX 
version 12.0 (Genetyx Co., Tokyo, Japan) was used to edit and assemble the nearly 
complete genome sequence. Annotations were performed using Geneious R9.1 (Kearse 
et al., 2012) with the built-in ORF finder of NCBI.  
III.2.5. Phylogenetic analysis 
 The phylogenetic relationships among primate bocaparvoviruses were inferred 
using the sequence data obtained in this study and reference sequences listed in Table 2.3. 
The sequences were aligned using MUSCLE in MEGA version 7.0 (Kumar et al., 2016) 
with default parameters for gap opening and gap extension. Phylogenetic trees were 
constructed in MEGA 7.0 (Kumar et al., 2016) using the maximum likelihood method 
with 1000 bootstrap replicates based on the models, which were chosen using the Find 
DNA/Protein models function in MEGA 7.0. The chosen models are listed in Table 2.4. 
III.2.6. Recombination analysis 
To identify potential recombination sites and possible nucleotide sequence 
topologies within the primate bocaparvoviruses, a nucleotide alignment of 7 strains 
representing the 7 primate bocaparvovirus genotypes reported to date (HBOV1 4, 
GBOV1, CPZh2, and GBOV2 of this study) was obtained using MAFFT version 7 (Katoh 
and Standley, 2013). A DualBrothers analysis was conducted using a built-in algorithm 
in Geneious R9.1 (Kearse et al., 2012) with default settings. The DualBrothers analysis 
is a recombination detection algorithm based on a phylogenetic dual multiple change-
point model (Minin et al., 2005); it allows the detection of spatial variation in the 
phylogenetic tree topology and spatial variation in nucleotide substitution events. 
Phylogenetic reconstructions of the regions showing different topologies I performed 
using MEGA7.0 (Kumar et al., 2016), as described above (Fig. 2.5 A-K). 
III.3. Results 
III.3.1. Detection of bocaparvoviruses in gorillas 
A PCR using pan-bocaparvovirus primers targeting a 244-bp fragment of the 
conserved NS1 gene, was performed on healthy gorillas of MDNP. Among 107 fecal 
samples, I detected bands of the expected size from 2 samples. I determined the nucleotide 
sequences of the DNA fragments, confirming they were partial bocapavovirus DNAs 
(data not shown). Interestingly, the nucleotide sequences were not identical to the 
counterparts of the known gorilla bocaparovirus GBOV1 (accession number: 
HM145750.1), and thus I tentatively named these viruses gorilla bocaparvovirus 2 
(GBOV2). GBOV2 showed 86-85.0% nucleotide and 93-87.1% amino acid identity with 
HBOV2 strains. 
To identify which gorilla individual(s) shed the viruses, I determined the 
microsatellite genotypes of 107 samples. The microsatellite analysis showed that the 107 
samples were derived from 26 individuals (Table 2.1). The two positive samples belonged 
to two different infants (approximately 2 years old). Therefore, the two strains were 
designated GBOV2/GAB1 and GBOV2/GAB2. 
III.3.2. Sequence analysis of the gorilla bocaparvoviruses 
 I subsequently determined the nearly complete genome sequences of 
GBOV2/GAB1 (4872 nucleotides) and GBOV2/GAB2 (4880 nucleotides) (Fig. 2.1B). 
Pairwise alignment of the two nucleotide sequences showed that they differ at only one 
nucleotide (position 135). The GC contents of the viruses were 40.9%. The genome 
organization was similar to those of other known primate bocaparvoviruses (Fig. 2.2A). 
The nearly complete genome contained three major ORFs. The left ORF encoded the 
putative NS1, consisting of 640 amino acids. Note that the splicing site in the NS gene 
was conserved in GBOV2 (Fig. 2.2B), suggesting that they also encode a spliced protein, 
i.e., NS2. The right ORF encoded the putative capsid protein VP1 (667 amino acids) and 
truncated capsid protein VP2 (538 amino acids). The middle ORF encoded the putative 
NP1 (216 amino acids). The putative viral proteins of GBOV2 shared similar features to 
those of closely related HBOVs, including the ATP-binding Walker-Loop (at amino acid 
positions 423 430) in the predicted NS1 protein (Fig.2.2C) and the phospholipase A2 in 
the unique region of VP1 (VP1u) (Fig.2.2D). The GBOV2 genome map is shown in Fig. 
2.2A-D. The nucleotide sequences were deposited in GenBank (accession numbers 
GBOV2/GAB1: KY581736; GBOV2/GAB2: KY581737). 
III.3.3. Phylogenetic analysis 
 To gain insight into the genetic relationships among primate bocaparvoviruses, I 
performed phylogenetic analyses using the nearly complete genome sequences (Fig. 2.3), 
NS gene (Fig. 2.7), NP gene (Fig. 2.8), and VP gene (Fig.2.9). Phylogenetic analysis 
based on the nearly complete genome, NS, VP, and NP genes (Fig. 2.3 and 2.7- 2.9) 
consistently indicated that the two GBOV2 strains form a well-supported cluster within 
the Primate bocaparvovirus 2 group. 
Because only partial sequences were available for some non-human primate 
bocaviruses, I performed phylogenetic analyses using 486 nucleotides of partial NS genes 
(Fig.2. 4A) and partial VP genes (Fig. 2.4B). Phylogenetic analysis based on the partial 
VP genes showed that GBOV2 strains also form a well-supported cluster within Primate 
bocaparvovirus 2. Interestingly, GBOV2 strains clustered with a chimpanzee strain found 
in Cameroon (HQ113150.1, Bocavirus chimpanzee/PT-LM1861/CMR isolate PT-
LM1861) in the partial VP tree, but not in the partial NS tree. 
III.3.4. Recombination analysis 
 I next performed a recombination analysis and identified possible breakpoints at 
several positions (Fig. 2.5A). Thus, to assess the topologies of each of the regions, I 
reconstructed phylogenetic trees using each of the nucleotide alignments (Fig. 2.5B-K). 
Within Primate bocaparvovirus 2, GBOV2 clustered with HBOV2 in the trees based 
on the alignments of nucleotide positions 1500 2336 and 2337 2640 (Figures 5 E-F), but 
not in the remaining trees (Fig. 2.5B 2.5D; 2.5G 2.5K), suggesting that there may have 
been an intra-species recombination event(s) during the evolution of those viruses. In 
addition, interestingly, I found that the chimpanzee strain CPZh2 was located in a cluster 
formed by the members of Primate bocaparvovirus 2 and HBOV3 (Figure 2.5H).  
III.4. Discussion 
 In this study, I detected two bocaparvoviruses from the feces of two habituated 
infant gorillas in MDNP, Gabon. I further determined the nearly complete genome 
sequences of the two strains, named GBOV2/GAB1 and GBOV2/GAB2. The strains were 
nearly identical and clustered with members of Primate bocaparvovirus 2. Based on the 
criteria of the International Committee of Taxonomy for Viruses (ICTV) (Cotmore et al., 
2014), GBOV2 strains were proposed to be  classified as belonging to Primate 
bocaparvovirus 2 because the deduced amino acid sequence of GBOV2 NS1 showed 
93.0 91.0% identities with HBOV2 NS1 sequences (Table 2.5). To my knowledge, all 
gorilla bocaparvoviruses reported to date belong to the species Primate bocaparvovirus 1. 
Therefore, this is the first report of a non-human primate bocaparvovirus in Primate 
bocaparvovirus 2. 
 At least two bocaparovirus species are circulating in wild gorillas. Only two 
previous studies have reported the presence of bocaparvoviruses in diseased captive and 
healthy free ranging gorillas (Kapoor et al., 2010a; Sharp et al., 2010), including 1 
GBOV1 strain and 2 gorilla bocaparvovirus-like sequences that are genetically similar to 
GBOV1. Therefore, I cannot further evaluate the differences among gorilla viruses, 
including the differences in geographical distribution and epidemiology of 
bocaparvoviruses in non-human primates. Further molecular epidemiological studies are 
needed to understand these issues. 
Based on microsatellite genotyping, the two gorillas in which GBOV2 was detected 
were both infants. Fewer samples were collected from infants than from adults or 
juveniles, suggesting that the higher incidence in infants was not due to sampling bias. 
Although the sample size was small to conclude a high incidence in infants, this infection 
pattern was consistent with that of human bocaparvoviruses, which show a relatively high 
incidence in children between 12 and 24 months (Ahn et al., 2014). HBOV2 and HBOV4 
have been detected in children of less than three years old suffering from acute 
gastroenteritis (Arthur et al., 2009) and bronchopneumonia (Song et al., 2010). Adult 
humans seem to be less susceptible to bocaparvovirus infection, probably owing to 
immunity acquired during early childhood (Ahn et al., 2014).  
 Importantly, the two infant gorillas in this study were apparently healthy. In various 
animals and humans, bocaparvovirus infection are mainly associated to respiratory and 
gastro-intestinal illnesses (Arthur et al., 2009; Lu et al., 2015). In non-human primates, 
however, its clinical significance or symptomatology remains unclear. CPZh2 was also 
 2016). Although GBoV1 
was identified from gorillas suffered from diarrhea, its etiological relationship is unclear 
(Kapoor 2010a). Further epidemiological studies are required to assess the clinical 
significance of bocaparvoviruses in non-human primates.  
Previous studies have suggested that multiple recombination events may have 
driven the evolution of primate bocaparvoviruses (Babkin et al., , 
2016; Chieochansin et al., 2010; Fu et al., 2011; Kapoor et al., 2009, 2010b; Khamrin et 
al., 2013; Tyumentsev et al., 2014; Zehender et al., 2010). Here, i newly identified intra- 
and inter-species recombination events among primate bocaparvoviruses (Fig.2. 5). 
Within Primate bocaparvovirus 2, i observed differences between the topologies of some 
trees; the closest relative of GBOV2 was HBoV2 in some trees (Fig.2.5E and F), but not 
all, trees (Fig.2. 5 B-D, G, I). Thus, members of Primate bocaparvovirus 2 may have 
experienced an intra-species recombination event during their evolution as reported 
elsewhere (Kapoor et al., 2010b). Interestingly, i also found evidence for inter-species 
recombination of bocaparvoviruses. In the tree based on nucleotide positions 3069 3374 
(Fig.2.5H), the chimpanzee strain CPZh2, a member of Primate bocaparvovirus 1, is 
clustered with members of Primate bocaparvovirus 2 and HBoV3, which was previously 
reported to be possibly a recombinant of HBoV1 and HBOV2 lineages (Arthur et al., 
2009; Chieochansin al., 2010; Wang et al. 2011). This observation suggests an inter-
species recombination event between members of Primate bocaparvovirus 1 and 2. Thus, 
the short segment of the CPZh2 strain may be derived from a Primate bocaparvovirus 2 
virus.  
In the phylogenetic analysis, i also found that a chimpanzee bocaparovirus strain, 
PT-LM1861/CMR isolate PT-LM1861, was located in different clusters in the partial NS 
tree and partial VP tree. These results suggest that the virus may be a recombinant virus, 
like HBoV3 (Sharp et al., 2010). Alternatively, the chimpanzee may have been co-
infected with two bocaparvovirus strains. Further sequence analyses are needed to 
determine the precise evolutionary history of these viruses. 
III. 5. Conclusions 
The discovery of the GBOV2 in wild infant gorillas suggests a high diversity of 
bocaparvoviruses in primates; there may be many undiscovered non-human primate 
bocaparvoviruses belonging to Primate bocaparvovirus 2. These findings emphasize the 
importance of assessing bocaparvovirus infections in wild non-human primates for a 
better understanding of the evolution and the safe management of the ape population. 









Number of positive 
individuals 
Silverback 7 1 0 0 
Adult female 20 4 0 0 
Sub-adults 8 2 0 0 
Juveniles 43 8 0 0 
Infants 4 3 2 2 
Others 25 8 0 0 
Total 107 26 2 2 
Table 2.2. Primers used for sequencing the gorilla bocaparvovirus 2 
Primer name Primer sequence  
Targeted nucleotide 
position* 
P1-Fouter 5'-GGCGAGTGAACATCTCTGGG-3' 206 225 
P2-Router 5'-AAGGTCACCTCGCTTGTCTC-3' 827 846 
P3-Finner 5'-TGGTGAGTGACACTATGGCC-3' 242 261 
P4-Rinner 5'-AGCCATGTAGCATGCTTTGC-3' 491 510 
P5-Router 5'-CTCCAAATGTTTGTGGTAGTTGC-3' 1878 1900 
P6-Finner 5'-CTGCTCCTGTAATTAGAGCTTTTTC-3' 266 290 
P7-Rinner 5'-GTACACAGCAGATGGCATGC-3' 1461 1480 
P8-Router -GACGAKTGGCGGMTSTC-3' 2573 2589 
P-9-Finner 5'-GGCGCAAGGTTGATAGAAC-3' 1294 1312 
P10-Fouter -GGATTTGTGTTTAACGATTGCAGAC-3' 1609 1633 
P11-Router 5'-ATGACCATGGTGTGCTGACA-3' 3695 3714 
P12-Finner -GGACTCTTTGTCCTACACATTCAC-3' 2021 2044 
P13-Rinner -GAAGTGTTTGGTTGAGGTTCA-3' 3401 3421 
P14-Fouter 5'-AGACGATTGGTCTCTTGGTG-3' 3251 3270 
P15-Router 5'-TCTGGTTATTGGATATCTGTCCC-3' 4639 4661 
P16-Finner 5'-TTGGTGGCATTATTGGCTC-3' 3265 3283 
P17-Fouter 5'-AAACCAACAAGCTGGATGAC-3' 4293 4312 
P18-Router -GTAMCGGCTAGGTTCGAGAC-3' 5047-5066 
P19-Rinner 5'-CTAGGTTCGAGACGGCAAC-3' 5165-5183 
*Reference position from GenBank database accession number GU048662. 
Table 2.3. Bocavirus sequences used for the phylogenetic inference 
Accession 
number 
Name Abbreviation Host Wild Captive**
KY581736 Gorilla bocaparvovirus 2* GBOV2 Gorilla +  
KY581737 Gorilla bocaparvovirus 2* GBOV2 Gorilla + 
HM145750.1  Bocavirus gorilla GBOV1 Gorilla  + 
KT223502.1 Primate bocaparvovirus 1 CPZh2 CPZh2 Chimpanzee + 












Chimpanzee +  
GU048662.1 Human_bocavirus_2_strain_CU47TH HBOV2_CU47TH Human 





FJ948860.1 Human_bocavirus_2_strain_W298 HBOV2_W298 Human   
EU082213.1 Human_bocavirus_2_strain_W153 HBOV2_W153 Human 
EU082214.1 Human_bocavirus_2_strain_W208 HBOV2_W208 Human   
KM624025.1 Human_bocavirus_strain_LZFB080 HBOV_LZFB080 Human 
GU301644.1 Human_bocavirus_2_isolate_LZ53819 HBOV2_LZ53819 Human   




HBOV_Rus-Nsc10-N751 Human   
GU048664.1 Human_bocavirus_2_strain_CU1557UK HBOV2_CU1557UK Human 
FJ170280.1 Human_bocavirus_2_isolate_UK-648 HBOV2_UK_648 Human   
GU048663.1 Human_bocavirus_2_strain_CU54TH HBOV2_CU54TH Human 
FJ375129.1 Human_bocavirus_isolate_SH3 HBOV_SH3 Human   
FJ170279.1 Human_bocavirus_2_isolate_PK-2255 HBOV2_PK2255 Human 
JX257046.1 Human_bocavirus_2_strain_BJQ435 HBOV2_BJQ435 Human   
GU301645.1 Human_bocavirus_2_isolate_LZ55602 HBOV2_LZ55602 Human 
KM624027.1 Human_bocavirus_strain_LZFB086 HBOV_LZFB086 Human   
KC461233.1 Human_bocavirus_strain_CMH-S011-11 HBOV_CMH-S011-11 Human 
GQ200737.1 Human bocavirus 2 isolate KU1 HBOV2_KU1 Human   
FJ170278.1 Human bocavirus 2c PK isolate PK-5510 HBOV2c_PK5510 Human 
FJ973561.2 Human bocavirus 4 NI strain NI-385 HBOV4_NI385 Human   
KJ649741.1 




Human bocavirus isolate RUS_NSC_11-
N2657 
HBOV_RUS_NSC_11_N2657 Human   
FJ973562.1 Human bocavirus 3 strain 3B-TU-A-210-0 Human 
EU918736.1 Human bocavirus 3 strain W471 HBOV3_W471 Human   
KM624026.1 Human bocavirus strain LZFB199 HBOV_LZFB199 Human 
GU048665.1 Human bocavirus 3 strain CU2139UK HBOV3_CU2139UK Human   
FJ948861.1 Human bocavirus 3 strain W855 HBOV3_W855 Human 
HM132056.1 Human bocavirus 3 isolate 46-BJ07 HBOV3_46-BJ07 Human   
GQ867667.1 Human bocavirus 3 strain IM10 HBOV3_IM10 Human 
GQ867666.1 Human bocavirus 3 strain MC8 HBOV3_MC8 Human   
JN086998.1  Human bocavirus strain HBOV3 HBOV3 Human 
EU984242.1 Human bocavirus isolate TW141_07 HBOVT_W141_07 Human 
JN794566.1 Human bocavirus isolate GZ9081 HBOV_GZ9081 Human   
EU984245.1 Human bocavirus isolate TW925_07 HBOV_TW925_07 Human 
JX887481.1 Human bocavirus strain ZJ68 HBOV_ZJ68 Human   
KJ684073.1 Human bocavirus isolate 2012GZ2332 HBOV_2012GZ2332 Human 
JF327788.1 Human bocavirus strain TUN4134 HBOV_TUN4134 Human   
EF450740.1 Human bocavirus isolate HK24 HBOV_HK24 Human 
AB481074.1 Human bocavirus strain: JPOC06-089 HBOV_JPOC06-089 Human   
AB481073.1 Human bocavirus strain: JPOC06-077 HBOV_JPOC06-077 Human 
JX434060.1 Human bocavirus isolate CQ90  HBOV_CQ90 Human   
DQ988934.2 Human bocavirus strain BJ3722 HBOV_BJ3722 Human 
EU984232.1 Human bocavirus isolate TW2715_06 HBOV_TW2715_06 Human   
*These viruses are named in this study. **Captive: hosted in a zoo. 
Table 2.4 List of models used for the Maximum Likelihood test 
Region Model Figure 
2-4872 HKY+G Figure 4 
16-1938 HKY+G Suppl. Figure 2 
2802-4797 GTR+G Suppl. Figure 3 
2168-2815 GTR+G Suppl. Figure 4 
890-1344 T92+G Figure 5A 
4077-4406 TN93+G Figure 5B 
1-133 T92+G Figure 6B 
134-864 T92+G Figure 6C 
865-1499 T92+I Figure 6D 
1500-2336 GTR+G Figure 6E 
2337-2640 T92+I Figure 6F 
2641-3068 T92+I Figure 6G 
3069-3374 TN93+I Figure 6H 
3375-3556 HKY+I Figure 6I 
3557-4034 TN93+I Figure 6J 
4259-4443 TN93+G Figure 5K 
Pairwise amino acid percentage identities of NS1 of GBOV2 and other 
primate bocaparvovirus reference strains.
Accession 
number 
Strain GBOV2 GBOV1 CPzh2 HBOV1 HBOV2 HBOV3 
KY581737 GBOV2 
HM145750.1 GBOV1 76.1 
KT223502.1 CPzh2 75.6 91.5 
JQ923422.1 HBOV1 77.2 92 90.5 
GU048662.1 HBOV2 92.8 76.4 75.7 77.9 
EU918736.1 HBOV3 76.7 91.1 93 91.4 77.2 
FJ973561.2 HBOV4 87.8 75 74.6 77.5 91.1 75.4 
Figure 2.1. (A) Schematic diagram of the PCR strategy (B) Gel electrophoresis results 













































Figure 2.3. Phylogenetic tree based on the complete coding sequences of primate 
bocaparvoviruses
AB481073.1 Human bocavirus strain: JPOC06-077
AB481074.1 Human bocavirus strain: JPOC06-089
JX434060.1 Human bocavirus isolate CQ90
EF450740.1 Human bocavirus isolate HK24
EU984245.1 Human bocavirus isolate TW925 07
EU984242.1 Human bocavirus isolate TW141 07
KJ684073.1 Human bocavirus isolate 2012GZ2332
DQ988934.2 Human bocavirus strain BJ3722
JX887481.1 Human bocavirus strain ZJ68
JF327788.1 Human bocavirus strain TUN4134
EU984232.1 Human bocavirus isolate TW2715 06
JN794566.1 Human bocavirus isolate GZ9081
HM145750.1 Bocavirus gorilla/GBoV1/2009
GQ867666.1 Human bocavirus 3 strain MC8
GQ867667.1 Human bocavirus 3 strain IM10
FJ973562.1 Human bocavirus 3 strain 3B-TU-A-210-07
HM132056.1 Human bocavirus 3 isolate 46-BJ07
FJ948861.1 Human bocavirus 3 strain W855
JN086998.1 Human bocavirus strain 3
KM624026.1 Human bocavirus strain LZFB199
GU048665.1 Human bocavirus 3 strain CU2139UK
EU918736.1 Human bocavirus 3 strain W471
Gorilla bocaparvovirus 2 _GAB1
Gorilla bocaparvovirus 2 _GAB2
EU082214.1 Human bocavirus 2 strain W208 
GU048664.1 Human bocavirus 2 strain CU1557UK
EU082213.1 Human bocavirus 2 strain W153
FJ170280.1 Human bocavirus 2 _UK-648
JQ964116.1 Human bocavirus_Rus-Nsc10-N386
JQ964115.1 Human bocavirus_Rus-Nsc10-N751
FJ948860.1 Human bocavirus 2_W298
FJ973558.1 Human bocavirus 2a_2A-TU-A-114-06
GU048663.1 Human bocavirus 2 _CU54TH 
KM624025.1 Human bocavirus_LZFB080
GU301644.1 Human bocavirus 2 _LZ53819
GU048662.1 Human bocavirus 2 _CU47TH
FJ973560.1 Human bocavirus 2b NI strain 2B-NI-213
FJ375129.1 Human bocavirus isolate SH3
JX257046.1 Human bocavirus 2 strain BJQ435
GU301645.1 Human bocavirus 2 isolate LZ55602
FJ170279.1 Human bocavirus 2 isolate PK-2255
GQ200737.1 Human bocavirus 2 isolate KU1
FJ170278.1 Human bocavirus 2c PK isolate PK-5510
KM624027.1 Human bocavirus strain LZFB086
KC461233.1 Human bocavirus strain CMH-S011-11
FJ973561.2 Human bocavirus 4 NI strain HBoV4-NI-385
KJ649741.1 Human bocavirus isolate RUS NSC 11-N2655





















Human bocavirus 1, 15 strains
HQ113148.1 Bocavirus chimpanzee/PT-LM1861/CMR_PT-BQ2392 
HQ113145.1 Bocavirus gorilla/GG-CP1426/CMR isolate GG-CP1426 
HQ113147.1 Bocavirus gorilla/GG-CP1426/CMR isolate GG-GB2155 
HM145750.1 Bocavirus gorilla/GBoV1
KT223502.1 Primate bocaparvovirus 1_ CPZh2 
HQ113146.1 Bocavirus chimpanzee/PT-LM1861/CMR_ PT-LM1861 
Human bocavirus 3, 12 strains
ACXXXX.GBOV2_GAB2
ACXXXXX.GBOV2_GAB1
Human bocavirus 4, 2 strains
Human bocavirus 2c
Human bocavirus 2b, 5 strains



















KT223502.1 Primate bocaparvovirus 1 isolate CPZh2
HQ113151.1 Bocavirus chimpanzee/PT-LM1861/CMR isolate PT-BQ2392
Human bocavrus 1, 15 strains1
Human bocavirus 2a,5 strains
Human bocavirus 2b, 5 strains
















































































































































Figure 2.5. Recombination analysis (continued)
The 21st century has been marked by the emergence in the human population of 
various diseases originating from animals (wildlife, domestic animals, etc.) (Taylor et al., 
2001) and causing significant morbidity and mortality (Muyembe-Tamfum et al., 2012; 
Suzuki and Nei, 2000) zation (WHO) has 
collaboration of health practitioners for the benefit of human, animal and environment 
health. Molecular epidemiological studies of  viruses infecting wild apes provide data in 
(Gibbs, 2014). 
The survey of adenoviruses infecting wild western lowland gorillas has revealed 
the presence of 3 species namely Human adenovirus B (HAdV-B), HAdV-C and HAdV-
E. The species HAdV-C was found in the local people living the vicinity of the park, but 
both gorilla and HAdVs of this study were genetically distinct. In addition, the description 
of HAdV-E closely related to chimpanzee strains highlights the possible ape-to-ape cross 
transmission of mastadenoviruses in the wild. 
 The survey of bocaparvoviruses revealed the presence of novel primate 
bocaparvovirus members of the species Primate bocaparvovirus 2. To date, all the non-
human primate bocaparvoviruses including gorillas and chimpanzee strains belong to the 
species Primate bocaparvovirus 1. The description of a new genotype of primate 
bocaparvovirus 2 in gorillas highlights the possible existence of more non-human primate 
bocaparvoviruses strains members of that species in the wild. 
IV.1. Genetic diversity and evolution of viruses  
The study of the genetic diversity and evolution of viruses in natural host 
populations provides a better understanding of the origin of viral diseases and their 
distribution among several hosts.  
Viruses infecting wild apes display a high genetic diversity such as 
mastadenoviruses (Hoppe, 2015; Wevers et al., 2011) but generally each primate is 
infected with a species-specific virus. Therefore, the close phylogenetic relationship 
between apes and humans (>98% homology) (Scally et al., 2012), coupled with the 
(mining, agriculture, eco-tourism, etc.), has led to an exceptionally high potential for 
pathogen exchange (Calvignac-Spencer et al., 2012; Gillespie et al., 2008; Woodford et 
al., 2002). Ape-to-human (and vice versa) as well as ape-to-ape cross-species 
transmissions have been documented (Calvignac-Spencer et al., 2012; Hoppe et al., 2015; 
Mouinga-Ondeme et al., 2012).  
More than 10 virus families have been reported so far in wild African apes 
(Calvignac-Spencer et al., 2012). The viruses infecting gorillas belong to 11 families 
including the Adenoviridae and the Parvoviridae (Table 4.1). The knowledge of the 
diversity and evolution of infectious agents in wild apes has contributed answering the 
question of origin of some of the human pathogens (Liu et al., 2010; Sharp and Hahn, 
2010; Switzer et al., 2006) such as the HIV and HTLV (Gao et al., 1999; Switzer et al., 
2006). 
Although most microorganisms identified in wild apes are enzootic without being 
associated with acute disease, several host switches may 
which can become more hazardous for the new host. However, it is difficult to study about 
the pathogenicity in the wild animals.  
Evolution of viral pathogens may lead to altered virulence, enhanced transmission, 
altered tissue tropisms, and striking new disease manifestations (Robinson et al., 2013; 
Tyumentsev et al., 2014). Recombination and mutation are the central mechanisms 
driving such evolution (Farkov et al., 2017). For RNA viruses, for example, the concerted 
activities of mutation and recombination are key to virus spread and virulence in infected 
animals (Farkov et al., 2017). For single stranded DNA viruses such as bocaparvoviruses 
which exhibit a high mutation rate close to that of RNA viruses, recombination has been 
shown to contribute to their evolution (Nze-Nkogue et al., 2017). Also, double stranded 
DNA viruses with lower mutation rate, such as adenoviruses, are also  prone to recombine 
(Robinson et al., 2013; Walsh et al., 2009).   
Several factors may affect the rate of recombination events, including the genome 
structure, presence of sites sensitive to nucleases, and the mechanisms of virus replication 
(Tyumentsev et al., 2014). In particular, replication of viruses with single-stranded DNA 
genomes suggests the generation of concatemeric intermediates, and the breakpoints of 
concatemers may be recombination hotspots (Tyumentsev et al., 2014).  
Homologous recombination is a critical mechanism for the maintenance of genome 
fitness and diversity (Eichler, 2009). Similarly, inter and intra-species recombination 
contribute to the virus diversity, and sometimes leading to the emergence of new 
variants or new viruses. The current study highlights the occurrence of recombination 
events in natural settings involving wild apes. The intra-species recombination among 
the members of primate bocaparvovirus 2 and the inter-species between both primate 
bocaparvovirus species (Nze-Nkogue et al., 2017) contribute to understand the mixed 
hosts origin of these viruses.  
IV.2. Conclusions and recommendations  
Epidemiological studies on microorganisms infecting wildlife have contributed to 
the understanding of the genetic diversity and the evolutionary history of the target agents.  
The knowledge of viral evolution is critical to predict and prevent future disease 
outbreaks. 
The description of several adenoviruses and the identification of novel 
bocaparvoviruses in wild western gorillas contribute to a better understanding of the 
genetic diversity of these viruses as well as to clarify their evolutionary processes. 
Considering the genetic relatedness between gorillas and human, I would advise the 
surveillance adenoviruses and bocaparvoviruses in gorillas as well as in humans (tourists, 
guides, local peoples, etc.) which potentially contact with these animals when eco-tourism 
is promoted. In addition, the continuation of the epidemiological study at a broader scale, 
i.e. the assessment of more viral families and in other ape populations in Gabon, is 
recommended. 
The recent use of advanced sequencing technologies such as high throughput 
approaches for pathogen assessment in various animals including wildlife (bats: (Li et al., 
2010) and domestic animals (pigs: (Amimo et al., 2016; Shan et al., 2011) has 
significantly increased the knowledge of microbial diversity in target animals which 
opens an important tool box for comprehending the natural history of various pathogens. 
The use of third generation sequencing such as MinION (Oxford Nanopore 
Technologies) which allows the screening of a broad range of microorganisms (RNA 
viruses for example) in short time could be considered for the study o
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